Literature DB >> 28978808

Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens.

Adrien Bosseboeuf1, Delphine Feron1, Anne Tallet2, Cédric Rossi3, Cathy Charlier4, Laurent Garderet5,6,7, Denis Caillot3, Philippe Moreau8, Marina Cardó-Vila9,10, Renata Pasqualini9,10, Wadih Arap10,11, Alfreda Destea Nelson10,12, Bridget S Wilson10,12, Hélène Perreault13, Eric Piver2,14, Pierre Weigel4, François Girodon15, Jean Harb16,17, Edith Bigot-Corbel1,17, Sylvie Hermouet1,18.   

Abstract

Subsets of mature B cell neoplasms are linked to infection with intracellular pathogens such as Epstein-Barr virus (EBV), hepatitis C virus (HCV), or Helicobacter pylori. However, the association between infection and the immunoglobulin-secreting (Ig-secreting) B proliferative disorders remains largely unresolved. We investigated whether the monoclonal IgG (mc IgG) produced by patients diagnosed with monoclonal gammopathy of undetermined significance (MGUS) or multiple myeloma (MM) targets infectious pathogens. Antigen specificity of purified mc IgG from a large patient cohort (n = 244) was determined using a multiplex infectious-antigen array (MIAA), which screens for reactivity to purified antigens or lysates from 9 pathogens. Purified mc IgG from 23.4% of patients (57 of 244) specifically recognized 1 pathogen in the MIAA. EBV was the most frequent target (15.6%), with 36 of 38 mc IgGs recognizing EBV nuclear antigen-1 (EBNA-1). MM patients with EBNA-1-specific mc IgG (14.0%) showed substantially greater bone marrow plasma cell infiltration and higher β2-microglobulin and inflammation/infection-linked cytokine levels compared with other smoldering myeloma/MM patients. Five other pathogens were the targets of mc IgG: herpes virus simplex-1 (2.9%), varicella zoster virus (1.6%), cytomegalovirus (0.8%), hepatitis C virus (1.2%), and H. pylori (1.2%). We conclude that a dysregulated immune response to infection may underlie disease onset and/or progression of MGUS and MM for subsets of patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28978808      PMCID: PMC5841870          DOI: 10.1172/jci.insight.95367

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  50 in total

1.  Oligo-monoclonal immunoglobulins frequently develop during concurrent cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections in patients after renal transplantation.

Authors:  E Drouet; C Chapuis-Cellier; S Bosshard; C Verniol; A Niveleau; J L Touraine; J L Garnier
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

Review 2.  MGUS to myeloma: a mysterious gammopathy of underexplored significance.

Authors:  Madhav V Dhodapkar
Journal:  Blood       Date:  2016-10-13       Impact factor: 22.113

Review 3.  XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus.

Authors:  Feng-Yen Li; Benjamin Chaigne-Delalande; Helen Su; Gulbu Uzel; Helen Matthews; Michael J Lenardo
Journal:  Blood       Date:  2014-02-18       Impact factor: 22.113

4.  Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group.

Authors:  C Seidel; M Børset; I Turesson; N Abildgaard; A Sundan; A Waage
Journal:  Blood       Date:  1998-02-01       Impact factor: 22.113

Review 5.  B cell antigen receptor signaling: roles in cell development and disease.

Authors:  Stephen B Gauld; Joseph M Dal Porto; John C Cambier
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

6.  From combinatorial peptide selection to drug prototype (II): targeting the epidermal growth factor receptor pathway.

Authors:  Marina Cardó-Vila; Ricardo J Giordano; Richard L Sidman; Lawrence F Bronk; Zhen Fan; John Mendelsohn; Wadih Arap; Renata Pasqualini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-26       Impact factor: 11.205

Review 7.  Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.

Authors:  Gregory F Sonnenberg; Lynette A Fouser; David Artis
Journal:  Nat Immunol       Date:  2011-05       Impact factor: 25.606

8.  Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.

Authors:  Kwai Fung Hui; Benjamin H W Lam; Dona N Ho; Sai Wah Tsao; Alan K S Chiang
Journal:  Mol Cancer Ther       Date:  2013-03-08       Impact factor: 6.261

Review 9.  Epstein-Barr virus latent genes.

Authors:  Myung-Soo Kang; Elliott Kieff
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

10.  The Role of IL-22 in Viral Infections: Paradigms and Paradoxes.

Authors:  Silvia Gimeno Brias; Gabrielle Stack; Maria A Stacey; Alec J Redwood; Ian R Humphreys
Journal:  Front Immunol       Date:  2016-05-30       Impact factor: 7.561

View more
  15 in total

Review 1.  [Pathogenesis of multiple myeloma].

Authors:  L Rasche; N Weinhold
Journal:  Internist (Berl)       Date:  2019-01       Impact factor: 0.743

2.  Absolute Quantitation of Glycoforms of Two Human IgG Subclasses Using Synthetic Fc Peptides and Glycopeptides.

Authors:  Rini Roy; Evelyn Ang; Emy Komatsu; Ronald Domalaon; Adrien Bosseboeuf; Jean Harb; Sylvie Hermouet; Oleg Krokhin; Frank Schweizer; Hélène Perreault
Journal:  J Am Soc Mass Spectrom       Date:  2018-05-23       Impact factor: 3.109

3.  Race-Dependent Differences in Risk, Genomics, and Epstein-Barr Virus Exposure in Monoclonal Gammopathies: Results of SWOG S0120.

Authors:  Madhav V Dhodapkar; Rachael Sexton; Antje Hoering; Frits Van Rhee; Bart Barlogie; Robert Orlowski
Journal:  Clin Cancer Res       Date:  2020-08-18       Impact factor: 12.531

4.  Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins.

Authors:  Adrien Bosseboeuf; Sophie Allain-Maillet; Nicolas Mennesson; Anne Tallet; Cédric Rossi; Laurent Garderet; Denis Caillot; Philippe Moreau; Eric Piver; François Girodon; Hélène Perreault; Sophie Brouard; Arnaud Nicot; Edith Bigot-Corbel; Sylvie Hermouet; Jean Harb
Journal:  Front Immunol       Date:  2017-10-19       Impact factor: 7.561

5.  Characteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1.

Authors:  Adrien Bosseboeuf; Nicolas Mennesson; Sophie Allain-Maillet; Anne Tallet; Eric Piver; Olivier Decaux; Caroline Moreau; Philippe Moreau; Philippe Lehours; Francis Mégraud; Valéry Salle; Edith Bigot-Corbel; Jean Harb; Sylvie Hermouet
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

Review 6.  Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.

Authors:  Alessandro Allegra; Vanessa Innao; Andrea Gaetano Allegra; Marta Pugliese; Eleonora Di Salvo; Elvira Ventura-Spagnolo; Caterina Musolino; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2019-06-10       Impact factor: 5.923

Review 7.  A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity.

Authors:  Matteo C Da Vià; Bachisio Ziccheddu; Akihiro Maeda; Filippo Bagnoli; Giulia Perrone; Niccolò Bolli
Journal:  Hemasphere       Date:  2020-11-24

Review 8.  Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma.

Authors:  Michael H Tomasson; Mahmoud Ali; Vanessa De Oliveira; Qian Xiao; Yogesh Jethava; Fenghuang Zhan; Adam M Fitzsimmons; Melissa L Bates
Journal:  Int J Mol Sci       Date:  2018-11-16       Impact factor: 5.923

9.  Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients.

Authors:  Adrien Bosseboeuf; Célia Seillier; Nicolas Mennesson; Sophie Allain-Maillet; Maeva Fourny; Anne Tallet; Eric Piver; Philippe Lehours; Francis Mégraud; Laureline Berthelot; Jean Harb; Edith Bigot-Corbel; Sylvie Hermouet
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

10.  Editorial: Structure, Isotypes, Targets, and Post-translational Modifications of Immunoglobulins and Their Role in Infection, Inflammation and Autoimmunity.

Authors:  Jean Harb; Bridget S Wilson; Sylvie Hermouet
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.